1-7 of 7
Reggie Kelly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of AMG 531 Efficacy in Splenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.

Terry B. Gernsheimer, Vinod Pullarkat, Francis M. Senecal, Louis M. Aledort, Craig M. Kessler, Miguel A. Sanz, Howard A. Liebman, Frank T. Slovick, Reggie Kelly, Matthew Guo, Janet Nichol
Journal: Blood
Blood (2007) 110 (11): 2.
https://doi.org/10.1182/blood.V110.11.2.2
Published: 2007
Journal Articles

Evaluation of AMG 531 Safety in Splenectomized (S) and Nonsplenectomized (NS) Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in Two Randomized Placebo-Controlled Phase 3 Studies

Roger Lyons, James N. George, Francois Lefrere, Alan E. Lichtin, Michael D. Tarantino, Howard R. Terebelo, Jean-Francois Viallard, Reggie Kelly, Matthew Guo, Janet Nichol
Journal: Blood
Blood (2007) 110 (11): 1300.
https://doi.org/10.1182/blood.V110.11.1300.1300
Published: 2007
Journal Articles

Evaluation of AMG 531 Efficacy in Nonsplenectomized Patients with Chronic Immune Thrombocytopenic Purpura (ITP) in a Randomized Placebo-Controlled Phase 3 Study.

David J. Kuter, James B. Bussel, Francis M. Senecal, Louis M. Aledort, Craig M. Kessler, Miguel A. Sanz, Howard A. Liebman, Frank T. Slovick, Reggie Kelly, Matthew Guo, Janet L. Nichol
Journal: Blood
Blood (2007) 110 (11): 565.
https://doi.org/10.1182/blood.V110.11.565.565
Published: 2007
Journal Articles

Long-Term Dosing of AMG 531 in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura: 48-Week Update.

David Kuter, James Bussel, James George, Louis Aledort, Alan Lichtin, Roger Lyons, Jorge Nieva, Jeffrey Wasser, Emanuelle Bourgeois, Mies Kappers-Klunne, Francois Lefrere, Martin Schipperus, Reggie Kelly, Jenny Christal, Matthew Guo, Janet Nichol
Journal: Blood
Blood (2006) 108 (11): 476.
https://doi.org/10.1182/blood.V108.11.476.476
Published: 2006
Journal Articles

Safety Profile of AMG 531 in Healthy Volunteers and in Thrombocytopenic Patients with Immune Thromobocytopenic Purpura.

Daniel E. Stepan, MD, Elaine Sergis-Deavenport, RN, MS, CPNP, Reggie Kelly, BS, Jenny Christal, PhD, Chien-Feng Chen, PhD, Janet L. Nichol, MS
Journal: Blood
Blood (2005) 106 (11): 1240.
https://doi.org/10.1182/blood.V106.11.1240.1240
Published: 2005
Journal Articles

Long-Term Dosing of AMG 531 Is Effective and Well Tolerated in Thrombocytopenic Patients with Immune Thrombocytopenic Purpura.

James B. Bussel, David J. Kuter, James N. George, Louis M. Aledort, Alan E. Lichtin, Roger M. Lyons, Jorge Nieva, Jeffrey S. Wasser, Emanuelle Bourgeois, Mies Kappers-Klunne, Francois LeFrere, Martin R. Schipperus, Reggie Kelly, Jenny Christal, Chien-Feng Chen, Janet L. Nichol
Journal: Blood
Blood (2005) 106 (11): 220.
https://doi.org/10.1182/blood.V106.11.220.220
Published: 2005
Journal Articles

A Phase 2 Placebo Controlled Study Evaluating the Platelet Response and Safety of Weekly Dosing with a Novel Thrombopoietic Protein (AMG531) in Thrombocytopenic Adult Patients (pts) with Immune Thrombocytopenic Purpura (ITP).

David Kuter, MD, DPhil, James B. Bussel, MD, Louis M. Aledort, MD, James George, MD, Roger M. Lyons, MD, George T. Conklin, MD, Alan E. Lichtin, MD, Jorge Nieva, MD, Reggie Kelly, BA, Chien-Feng Chen, PhD, Janet L. Nichol, MS
Journal: Blood
Blood (2004) 104 (11): 511.
https://doi.org/10.1182/blood.V104.11.511.511
Published: 2004